Gates Foundation to invest up to $90M in vaccine maker Inventprise

Redmond-based vaccine maker Inventprise is gaining serious backing from the Bill& Melinda Gates Foundation. On Wednesday, the biotech company announced an investment from the foundation of up to $90 million, contingent on manufacturing, clinical and preclinical milestones. The foundation is investing in IVT-25, a vaccine targeting pneumococcal bacterial infections. Pneumococcus can cause infections like pneumonia and meningitis. "High rates of morbidity and mortality due to pneumococcal disease…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news